Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mathivet

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Cellular Signalling|October 2, 2007
In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?Thomas Mathivet, Pierre Mazot, Marc Vigny
Medecine Sciences : M/S|July 12, 2014
[Protection of vascular integrity in reperfusion during stroke]Claire Bouleti, Thomas Mathivet, Bertrand Lapergue, et al.
Dalton Transactions (Cambridge, England : 2003)|November 26, 2008
Cationic borohydrido-neodymium complex: synthesis, characterization and its application as an efficient pre-catalyst for isoprene polymerisationMarc Visseaux, Michael Mainil, Michael Terrier, et al.
Neuro-Oncology Advances|November 18, 2020
Long-lived tumor-associated macrophages in gliomaPetya B Georgieva, Thomas Mathivet, Silvanus Alt, et al.
International Journal of Pharmaceutics|February 7, 2016
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapyRémi Rosière, Matthias Van Woensel, Véronique Mathieu, et al.
Circulation Research|June 30, 2016
Sympathetic Innervation Promotes Arterial Fate by Enhancing Endothelial ERK ActivityLuc Pardanaud, Laurence Pibouin-Fragner, Alexandre Dubrac, et al.
Developmental Cell|March 17, 2012
ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathwayBruno Larrivée, Claudia Prahst, Emma Gordon, et al.
Frontiers in Immunology|June 20, 2019
Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian CancerThaïs Baert, Ann Vankerckhoven, Matteo Riva, et al.
Cells|February 5, 2020
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot StudyAnn Vankerckhoven, Roxanne Wouters, Thomas Mathivet, et al.
Nature Communications|November 25, 2016
The Robo4 cytoplasmic domain is dispensable for vascular permeability and neovascularizationFeng Zhang, Claudia Prahst, Thomas Mathivet, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Cellular Signalling|October 2, 2007
In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?Thomas Mathivet, Pierre Mazot, Marc Vigny
Medecine Sciences : M/S|July 12, 2014
[Protection of vascular integrity in reperfusion during stroke]Claire Bouleti, Thomas Mathivet, Bertrand Lapergue, et al.
Dalton Transactions (Cambridge, England : 2003)|November 26, 2008
Cationic borohydrido-neodymium complex: synthesis, characterization and its application as an efficient pre-catalyst for isoprene polymerisationMarc Visseaux, Michael Mainil, Michael Terrier, et al.
Neuro-Oncology Advances|November 18, 2020
Long-lived tumor-associated macrophages in gliomaPetya B Georgieva, Thomas Mathivet, Silvanus Alt, et al.
International Journal of Pharmaceutics|February 7, 2016
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapyRémi Rosière, Matthias Van Woensel, Véronique Mathieu, et al.
Circulation Research|June 30, 2016
Sympathetic Innervation Promotes Arterial Fate by Enhancing Endothelial ERK ActivityLuc Pardanaud, Laurence Pibouin-Fragner, Alexandre Dubrac, et al.
Developmental Cell|March 17, 2012
ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathwayBruno Larrivée, Claudia Prahst, Emma Gordon, et al.
Frontiers in Immunology|June 20, 2019
Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian CancerThaïs Baert, Ann Vankerckhoven, Matteo Riva, et al.
Cells|February 5, 2020
Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot StudyAnn Vankerckhoven, Roxanne Wouters, Thomas Mathivet, et al.
Nature Communications|November 25, 2016
The Robo4 cytoplasmic domain is dispensable for vascular permeability and neovascularizationFeng Zhang, Claudia Prahst, Thomas Mathivet, et al.
Pageof 6